Publicaciones (24) Publicaciones en las que ha participado algún/a investigador/a

2006

  1. 1.1. Neurotransmisores y mensajeros intracelulares

    Tratado SET de Trastornos Adictivos (Editorial Médica Panamericana), pp. 1-6

  2. 1.6. Aprendizaje, memoria y motivación

    Tratado SET de Trastornos Adictivos (Editorial Médica Panamericana), pp. 23-28

  3. Acute and long-term administration of citalopram desensitizes α2-adrenoceptors in the rat vas deferens

    Journal of Pharmacy and Pharmacology, Vol. 58, Núm. 3, pp. 367-373

  4. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease

    Amino Acids, Vol. 31, Núm. 4, pp. 449-456

  5. Cannabinoid system in the budgerigar brain

    Brain Research, Vol. 1087, Núm. 1, pp. 105-113

  6. Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates

    Neuroscience, Vol. 140, Núm. 2, pp. 635-643

  7. Cyclic AMP-dependent and Epac-mediated activation of R-Ras by G protein-coupled receptors leads to phospholipase D stimulation

    Journal of Biological Chemistry, Vol. 281, Núm. 31, pp. 21837-21847

  8. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol

    Journal of Physiology, Vol. 577, Núm. 1, pp. 263-280

  9. Development of new drugs that act through membrane receptors and involve an action of inverse agonism.

    Recent patents on CNS drug discovery, Vol. 1, Núm. 2, pp. 207-217

  10. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: Effects of subthalamotomy and levodopa treatment

    Brain Research, Vol. 1084, Núm. 1, pp. 175-184

  11. Estimación del exceso de riesgo de mortalidad por cáncer de pulmón asociado a la exposición al humo ambiental de tabaco en trabajadores de la hostelería

    Medicina Clinica, Vol. 126, Núm. 1, pp. 13-14

  12. Greater allergenicity of topical ketoprofen in contact dermatitis confirmed by use

    Contact Dermatitis, Vol. 54, Núm. 5, pp. 239-243

  13. Heterotrimeric G proteins: Insights into the neurobiology of mood disorders

    Current Neuropharmacology, Vol. 4, Núm. 2, pp. 127-138

  14. In vivo effect of tramadol on locus coeruleus neurons is mediated by α2-adrenoceptors and modulated by serotonin

    Neuropharmacology, Vol. 51, Núm. 1, pp. 146-153

  15. Levels of G-protein αq/11 subunits and of phospholipase C-β(1-4), -γ, and -δ1 isoforms in postmortem human brain caudate and cortical membranes: Potential functional implications

    Neurochemistry International, Vol. 49, Núm. 1, pp. 72-79

  16. Los receptores para imidazolinas I 2 como posible marcador de malignidad en tumores gliales humanos

    Revista de Neurologia, Vol. 43, Núm. 8, pp. 476-480

  17. Pharmacological characterization and autoradiographic distribution of α2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain

    Neuroscience, Vol. 141, Núm. 1, pp. 357-369

  18. Screening for MECP2 mutations in Spanish patients with an unexplained mental retardation

    Clinical Genetics, Vol. 70, Núm. 2, pp. 140-144

  19. Separation of μ-opioid receptor desensitization and internalization: Endogenous receptors in primary neuronal cultures

    Journal of Neuroscience, Vol. 26, Núm. 15, pp. 4118-4125

  20. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the μ-opioid receptor and I2-imidazoline binding sites

    Bioorganic and Medicinal Chemistry, Vol. 14, Núm. 19, pp. 6570-6580